vs
DBV Technologies S.A.（DBVT）与MESABI TRUST（MSB）财务数据对比。点击上方公司名可切换其他公司
MESABI TRUST的季度营收约是DBV Technologies S.A.的1.3倍（$3.6M vs $2.8M），MESABI TRUST净利率更高（77.1% vs -1195.5%，领先1272.6%），DBV Technologies S.A.同比增速更快（158.8% vs -95.5%），过去两年DBV Technologies S.A.的营收复合增速更高（12.4% vs -24.1%）
DBV Technologies是一家总部位于法国巴涅的公开上市生物制药企业，核心研发成果为Viaskin给药技术，可在不进入血液循环的前提下，让过敏原或抗原作用于完整皮肤。其花生过敏疗法Viaskin Peanut的临床开发，已获得美国食品药品监督管理局授予快速通道资格。
梅萨比信托是一家总部位于美国的特许权信托机构，持有明尼苏达州梅萨比山脉铁矿开采资产的特许权权益，主要通过与铁矿石生产销售挂钩的特许权使用费获得收益，服务于全球钢铁制造市场。
DBVT vs MSB — 直观对比
营收规模更大
MSB
是对方的1.3倍
$2.8M
营收增速更快
DBVT
高出254.2%
-95.5%
净利率更高
MSB
高出1272.6%
-1195.5%
两年增速更快
DBVT
近两年复合增速
-24.1%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $3.6M |
| 净利润 | $-33.2M | $2.8M |
| 毛利率 | — | 77.1% |
| 营业利润率 | -1235.7% | — |
| 净利率 | -1195.5% | 77.1% |
| 营收同比 | 158.8% | -95.5% |
| 净利润同比 | -8.9% | -96.5% |
| 每股收益（稀释后） | $-0.24 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DBVTMSB
| Q4 25 | — | $3.6M | ||
| Q3 25 | $2.8M | $5.6M | ||
| Q2 25 | $1.5M | $4.7M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $79.0M | ||
| Q3 24 | — | $6.5M | ||
| Q2 24 | $1.2M | $6.3M | ||
| Q1 24 | $1.4M | $6.2M |
净利润DBVTMSB
| Q4 25 | — | $2.8M | ||
| Q3 25 | $-33.2M | $4.7M | ||
| Q2 25 | $-41.9M | $3.6M | ||
| Q1 25 | — | $6.1M | ||
| Q4 24 | — | $78.3M | ||
| Q3 24 | — | $5.4M | ||
| Q2 24 | $-33.1M | $3.5M | ||
| Q1 24 | $-27.3M | $4.7M |
毛利率DBVTMSB
| Q4 25 | — | 77.1% | ||
| Q3 25 | — | 84.6% | ||
| Q2 25 | — | 76.7% | ||
| Q1 25 | — | 88.5% | ||
| Q4 24 | — | 99.1% | ||
| Q3 24 | — | 83.2% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 75.3% |
营业利润率DBVTMSB
| Q4 25 | — | — | ||
| Q3 25 | -1235.7% | — | ||
| Q2 25 | -2806.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2914.9% | — | ||
| Q1 24 | -2029.7% | — |
净利率DBVTMSB
| Q4 25 | — | 77.1% | ||
| Q3 25 | -1195.5% | 84.6% | ||
| Q2 25 | -2858.4% | 76.7% | ||
| Q1 25 | — | 88.5% | ||
| Q4 24 | — | 99.1% | ||
| Q3 24 | — | 83.2% | ||
| Q2 24 | -2852.4% | 55.7% | ||
| Q1 24 | -1943.5% | 75.3% |
每股收益（稀释后）DBVTMSB
| Q4 25 | — | — | ||
| Q3 25 | $-0.24 | — | ||
| Q2 25 | $-0.31 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.34 | — | ||
| Q1 24 | $-0.28 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $52.9M | $21.1M |
| 总资产 | $110.5M | $26.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DBVTMSB
| Q4 25 | — | — | ||
| Q3 25 | $69.8M | — | ||
| Q2 25 | $103.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.2M | — | ||
| Q1 24 | $101.5M | — |
股东权益DBVTMSB
| Q4 25 | — | $21.1M | ||
| Q3 25 | $52.9M | $22.8M | ||
| Q2 25 | $86.2M | $19.6M | ||
| Q1 25 | — | $23.3M | ||
| Q4 24 | — | $95.3M | ||
| Q3 24 | — | $22.1M | ||
| Q2 24 | $79.1M | $20.7M | ||
| Q1 24 | $111.7M | $21.0M |
总资产DBVTMSB
| Q4 25 | — | $26.0M | ||
| Q3 25 | $110.5M | $24.8M | ||
| Q2 25 | $143.4M | $27.4M | ||
| Q1 25 | — | $101.7M | ||
| Q4 24 | — | $100.7M | ||
| Q3 24 | — | $26.2M | ||
| Q2 24 | $114.2M | $25.1M | ||
| Q1 24 | $145.9M | $26.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.4M | $3.5M |
| 自由现金流经营现金流 - 资本支出 | $-32.6M | — |
| 自由现金流率自由现金流/营收 | -1173.5% | — |
| 资本支出强度资本支出/营收 | 4.2% | — |
| 现金转化率经营现金流/净利润 | — | 1.27× |
| 过去12个月自由现金流最近4个季度 | $-138.3M | — |
8季度趋势，按日历期对齐
经营现金流DBVTMSB
| Q4 25 | — | $3.5M | ||
| Q3 25 | $-32.4M | $4.4M | ||
| Q2 25 | $-33.9M | $2.1M | ||
| Q1 25 | — | $93.9M | ||
| Q4 24 | — | $78.2M | ||
| Q3 24 | — | $3.8M | ||
| Q2 24 | $-35.1M | $2.5M | ||
| Q1 24 | $-34.7M | $14.6M |
自由现金流DBVTMSB
| Q4 25 | — | — | ||
| Q3 25 | $-32.6M | — | ||
| Q2 25 | $-33.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-35.8M | — | ||
| Q1 24 | $-36.0M | — |
自由现金流率DBVTMSB
| Q4 25 | — | — | ||
| Q3 25 | -1173.5% | — | ||
| Q2 25 | -2316.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3084.0% | — | ||
| Q1 24 | -2560.6% | — |
资本支出强度DBVTMSB
| Q4 25 | — | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 63.0% | — | ||
| Q1 24 | 94.9% | — |
现金转化率DBVTMSB
| Q4 25 | — | 1.27× | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 15.48× | ||
| Q4 24 | — | 1.00× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | 3.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
